Natriuretic Effect and Changes in Renal Haemodynamics Induced by Enalapril in Essential Hypertension
- 1 January 1985
- journal article
- Published by Springer Nature in Drugs
- Vol. 30 (Supplement) , 49-58
- https://doi.org/10.2165/00003495-198500301-00008
Abstract
The purpose of this study was to evaluate the natriuretic effect and renal haemodynamic changes induced by enalapril in patients with essential hypertension. In a group of 11 patients with mild to moderate hypertension with normal renal function, and on a controlled sodium intake (80 mmol/day), a decrease in systolic and diastolic blood pressure was observed (p <0.001) after 16 weeks of enalapril treatment (20 mg/day), without a change in heart rate. An increase in plasma renin activity (p <0.05) without changes in serum aldosterone, and a decrease in exchangeable sodium (p <0.001) were present at the end of the treatment period. In 10 hypertensive patients also taking a dietary sodium of 80 mmol/day, the renal haemodynamics, humoral changes, and urinary sodium excretion were measured during 4 days of enalapril treatment (20 mg/day). There was an increase in urinary sodium excretion on the 3rd and 4th days of treatment (p < 0.01). The effective renal plasma flow and fractional sodium excretion increased 72 hours after the beginning of treatment (p < 0.01); the glomerular filtration rate did not change, and filtration fraction decreased at 72 hours. Mean blood pressure fell 2 hours after the first dose (p <0.01), and the maximum drop in intrarenal vascular resistance occurred after 72 hours of treatment (p <0.01). Plasma renin activity increased (p < 0.05) and serum aldosterone decreased (p <0.01) 2 hours after the first dose. Thereafter, serum aldosterone increased progressively until it reached values similar to those with placebo at 48 and 72 hours of treatment. Urinary kallikrein fell during the 2nd and 3rd day of treatment (p <0.01). It was concluded that the decrease in exchangeable sodium was due to a natriuretic effect of enalapril. This effect presumably results from renal haemodynamic changes due to the reduction of angiotensin II. Other mechanisms, such as the reduction of aldosterone and accumulation of kinins, could be contributory factors.Keywords
This publication has 50 references indexed in Scilit:
- Time Course and Effect of Sodium Intake on Vascular and Hormonal Responses to Enalapril (MK 421) in Normal SubjectsJournal of Cardiovascular Pharmacology, 1983
- The angiotensin converting enzyme inhibitor enalapril and its effects on renal function.1983
- CaptoprilDrugs, 1983
- Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone.Heart, 1983
- Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade.1982
- Role of the intrarenal renin-angiotensin system in the control of renal function.Circulation Research, 1981
- LONG-TERM EFFECTS OF CAPTOPRIL (SQ14 225) ON BLOOD-PRESSURE AND HORMONE LEVELS IN ESSENTIAL HYPERTENSIONThe Lancet, 1979
- Aldosterone and its stimuli in normal and hypertensive man: are essential hypertension and primary hyperaldosteronism without tumour the same condition?1979
- Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patientsProgress in Cardiovascular Diseases, 1978
- THE MEASUREMENT OF THE TUBULAR EXCRETORY MASS, EFFECTIVE BLOOD FLOW AND FILTRATION RATE IN THE NORMAL HUMAN KIDNEYJournal of Clinical Investigation, 1938